Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Adaptimmune Therapeutics plc. (8/2/18). "Press Release: Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update". Philadeliphia, PA & Oxford.

Organisations Organisation Adaptimmune Therapeutics plc (Nasdaq: ADAP)
  Group Adaptimmune (Group)
  Organisation 2 GlaxoSmithKline plc (LSE: GSK, NYSE: GSK)
  Group GlaxoSmithKline (GSK) (Group)
Products Product MAGE-A10 SPEAR™ T-cell therapy
  Product 2 NY-ESO SPEAR® T-cell therapy
Person Person Noble, James (Adaptimmune 201909– Non-Executive Director before CEO before MediGene + Avidex)
     


   
Record changed: 2018-08-11

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Adaptimmune (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top